RIPK1-IN-21 (Compound I-5) is an inhibitor of RIPK1 with an EC50 value of 14.8 nM. RIPK1-IN-21 can be used in the research of neurodegenerative, autoimmune, and inflammatory diseases[1].

RIPK1-IN-13 (compound 28) is a selective inhibitor for receptor-interacting serine/threonine-protein kinase 1 (RIPK1), the inhibitory activity is measured by ADP-Glo Kinase Assay with a pKi of 7.66. RIPK1-IN-13 inhibits human leukaemia cells U937 with a pIC50 of 7.2[1].

RIPK1-IN-23 (compound 19) is a RIPK1 inhibitor with potent anti-necroptotic effects in HT-29 cells (EC50 of 1.7 nM). RIPK1-IN-23 shows anti-inflammatory activities[1].

RIPK2 Human Pre-designed siRNA Set A contains three designed siRNAs for RIPK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ripk2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ripk2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ripk2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ripk2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

RIPK3 Human Pre-designed siRNA Set A contains three designed siRNAs for RIPK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ripk3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ripk3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ripk3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ripk3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

RIPK4 Human Pre-designed siRNA Set A contains three designed siRNAs for RIPK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RIPOR2 Human Pre-designed siRNA Set A contains three designed siRNAs for RIPOR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Risdiplam-hydroxylate-d3 is a Risdiplam-hydroxylate tritium substitute. Risdiplam (RG7916) is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels[1].

Risdiplam-hydroxylate-d6 is a Risdiplam-hydroxylate tritium substitute. Risdiplam (RG7916) is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels[1].

RIT1 Human Pre-designed siRNA Set A contains three designed siRNAs for RIT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RIT2 Human Pre-designed siRNA Set A contains three designed siRNAs for RIT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RITA1 Human Pre-designed siRNA Set A contains three designed siRNAs for RITA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ritonavir (Standard) is the analytical standard of Ritonavir. This product is intended for research and analytical applications. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.

Ritonavir (Standard) is the analytical standard of Ritonavir. This product is intended for research and analytical applications. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.

Ritonavir (Standard) is the analytical standard of Ritonavir. This product is intended for research and analytical applications. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.

Ritonavir (Standard) is the analytical standard of Ritonavir. This product is intended for research and analytical applications. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.

Ritonavir (Standard) is the analytical standard of Ritonavir. This product is intended for research and analytical applications. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.

Ritonavir-d8 is deuterated labeled Ritonavir (HY-90001). Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.

Rivastigmine (tartrate) (Standard) is the analytical standard of Rivastigmine (tartrate). This product is intended for research and analytical applications. Rivastigmine tartrate (ENA 713; SDZ-ENA 713) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM, 4.15 μM, respectively. Rivastigmine tartrate can pass the blood […]

Rivastigmine-d3 hydrochloride is deuterated labeled Rivastigmine (HY-17368). Rivastigmine (S-Rivastigmine) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM , 4.15 μM, respectively. Rivastigmine can pass the blood brain barrier (BBB). Rivastigmine is a parasympathomimetic or cholinergic agent used for the research of mild […]

Rivenprost (ONO-4819; ONO-AE1-734) is a selective agonist for prostaglandin E receptor EP4 with Ki of 0.7 nM. Rivenprost exhibits hepatoprotective and bone anabolic effects[1][2].

Rizatriptan (benzoate) (Standard) is the analytical standard of Rizatriptan (benzoate). This product is intended for research and analytical applications. Rizatriptan benzoate (Maxalt) is a 5-HT1 agonist.

RK-682 hemicalcium is the calcium salt form of RK-682[1].

PKH is a TLR4 antagonist. PKH is a novel tripeptide and can be isolated from Akkermansia muciniphila. RKH reduces sepsis-induced inflammatory cell activation and proinflammatory factor overproduction[1].

RKH acetate exerts protective effects against sepsis-induced death and organ damage. RKH acetate can directly bind to Toll-like receptor 4 (TLR4) and block TLR4 signal transduction in immune cells[1].

RLBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for RLBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RLF Human Pre-designed siRNA Set A contains three designed siRNAs for RLF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RLIM Human Pre-designed siRNA Set A contains three designed siRNAs for RLIM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RLN1 Human Pre-designed siRNA Set A contains three designed siRNAs for RLN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RLN2 Human Pre-designed siRNA Set A contains three designed siRNAs for RLN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RLN3 Human Pre-designed siRNA Set A contains three designed siRNAs for RLN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RMC1 Human Pre-designed siRNA Set A contains three designed siRNAs for RMC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RMDN3 Human Pre-designed siRNA Set A contains three designed siRNAs for RMDN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RMI1 Human Pre-designed siRNA Set A contains three designed siRNAs for RMI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RMI2 Human Pre-designed siRNA Set A contains three designed siRNAs for RMI2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RMND1 Human Pre-designed siRNA Set A contains three designed siRNAs for RMND1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RMND5A Human Pre-designed siRNA Set A contains three designed siRNAs for RMND5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RNase A (10mg/mL, DNase free) is a ribonuclease used to catalyze RNA degradation without containing DNase. RNase A is often employed in cell cycle assay[1][2].

RNase L-IN-1 (compound 17a) trihydrochloride is an inhibitor of RNase L or ribonuclease L. RNase L degrades RNA to prevent viral replication and mediates innate immune responses and inflammation[1].

RNase L-IN-1 (compound 17a) trihydrochloride is an inhibitor of RNase L or ribonuclease L. RNase L degrades RNA to prevent viral replication and mediates innate immune responses and inflammation[1].